Ondine Biomedical Inc. (LON:OBI – Get Free Report) traded down 2% during mid-day trading on Tuesday . The company traded as low as GBX 8.58 ($0.11) and last traded at GBX 8.62 ($0.11). 158,609 shares were traded during trading, a decline of 6% from the average session volume of 168,652 shares. The stock had previously closed at GBX 8.80 ($0.11).
Ondine Biomedical Trading Down 2.6 %
The company’s fifty day moving average is GBX 8.30 and its 200-day moving average is GBX 7.63. The company has a debt-to-equity ratio of 1,847.37, a current ratio of 0.80 and a quick ratio of 8.26. The company has a market capitalization of £24.30 million, a PE ratio of -292.17 and a beta of 0.10.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Featured Stories
- Five stocks we like better than Ondine Biomedical
- Pros And Cons Of Monthly Dividend Stocks
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Energy and Oil Stocks Explained
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Stock Market Upgrades: What Are They?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
